ALLISON DRAKE: Open Payments
NPI 1760799985 · ALBANY, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,509 in 105 payments from 23 companies in 2025. Trend: 2023 $6,963 · 2024 $3,104 · 2025 $2,509
Food & beverage: $2,509
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 13 | $507 |
| Novo Nordisk Inc | 19 | $387 |
| Lilly USA, LLC | 11 | $258 |
| AstraZeneca Pharmaceuticals LP | 6 | $243 |
| Optinose US, Inc. | 10 | $180 |
| GlaxoSmithKline, LLC. | 10 | $165 |
| Exact Sciences Corporation | 6 | $137 |
| Gilead Sciences, Inc. | 1 | $122 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $80 |
| Phathom Pharmaceuticals, Inc. | 7 | $78 |
Products named: VRAYLAR, Xhance, QULIPTA, Wegovy, BREZTRI, The Cologuard Plus Collection Kit, Yeztugo, MOUNJARO.
Industry payments across NY — which companies pay providers there.
